How COVID antibody cocktails could help protect unvaccinated people


Regeneron's antibody cocktail could effectively provide "immediate protection to unvaccinated people," the company said Monday.
Regeneron announced that in a phase 3 trial, its monoclonal antibody cocktail protected against COVID-19 among people who were living with someone infected with the coronavirus, The New York Times reports.
This trial consisted of 1,505 people who lived in the same household as a person who tested positive for COVID-19 within the previous four days, and the antibody cocktail reduced the risk of symptomatic COVID-19 by 81 percent. Regeneron says it will ask the FDA to expand the emergency use authorization given to the antibody cocktail, which is now used for high-risk people infected with COVID-19.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"These antibodies may be particularly useful in individuals who are not yet vaccinated, and may also have potential in those who are immunosuppressed and may not respond well to vaccines," Dan Barouch, the trial's co-principal investigator, said.
Regeneron Chief Scientific Officer George Yancopoulos also said the antibody cocktail "may help provide immediate protection to unvaccinated people who are exposed to the virus." This study was the newest evidence suggesting that drugs of this kind "not only prevent the worst outcomes of the disease when given early enough, but also help prevent people from getting sick in the first place," the Times wrote, while The Wall Street Journal noted the Regeneron drug could "provide temporary stopgap protection as people await vaccines."
Myron Cohen, one of the lead investigators of the study, also pointed out to Stat News that it's a "really, really big deal" that the Regeneron study administered the antibody drug via an injection, as needing to start an IV to use such antibody drugs has "unequivocally" been a barrier.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows